Nuvectis Pharma, Inc. (NVCT )

Currency in USD Disclaimer
$5.39 -$0.02 (-0.37%)
Closed 01/02/2025
$5.33
$5.89
$4.44
$12.1

Company brief: NUVECTIS PHARMA, INC. (NVCT )


Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology. It develops NXP800, a novel heat shock factor 1 pathway inhibitor for the treatment of various cancers; and NXP900, a small molecule drug candidate to inhibit the Proto-oncogene c-Src and YES1 kinases. The company was incorporated in 2020 and is based in Fort Lee, New Jersey.

NVCT Corporation News

Income Statement